Regulatory modernization to support innovation and growth
Innovation in the pharmaceutical industry requires the right incentives, and such incentives can be diverse. Sufficient regulatory protection and adequate
Read moreInnovation in the pharmaceutical industry requires the right incentives, and such incentives can be diverse. Sufficient regulatory protection and adequate
Read moreEuropean healthcare stands at a pivotal moment. The pandemic may feel a lifetime ago, but we are yet to fully
Read moreWith 7million reported COVID-19 deaths and over 19 million excess deaths estimated worldwide by January 2023, COVID-19 brought to the
Read moreA resilient and dynamic ecosystem for healthcare innovation is key to strengthening the European Union. A comprehensive strategy brings patient
Read moreWhen the COVID-19 pandemic hit, countries around the globe were caught off guard. In Europe, each country initially responded on
Read moreIn the wake of the global COVID-19 crisis, Europe stands at a critical juncture in shaping its health policies and
Read moreThe start of the decade has crystallised the importance of healthcare policy, particularly due to the COVID-19 pandemic. This global
Read moreIntroduction Over the past few decades, Europe’s manufacturing base for off-patent medicines, APIs, and starting materials has gradually decreased. This
Read more